Long-term Oral Clarithromycin Administration in Chelonians with Subclinical Mycoplasma spp. Infection

Christy L. Rettenmund; Donal M. Boyer; William J. Orrico; Sarah G. Parker; Rebecca P. Wilkes; Tracie A. Seimon; Jean A. Paré

doi:10.5818/1529-9651-27.1-2.58

How to translate text using browser tools

1 March 2017 Long-term Oral Clarithromycin Administration in Chelonians with Subclinical Mycoplasma spp. Infection

Christy L. Rettenmund, Donal M. Boyer, William J. Orrico, Sarah G. Parker, Rebecca P. Wilkes, Tracie A. Seimon, Jean A. Paré

Author Affiliations +

J. of Herpetological Medicine and Surgery, 27(1-2):58-61 (2017). https://doi.org/10.5818/1529-9651-27.1-2.58

Abstract

Choanal swabs were collected three times at 2 wk intervals from 17 asymptomatic captive chelonians, eight Forsten's tortoises (Indotestudo forstenii) and nine Sulawesi forest turtles (Leucocephalon yuwonoi), to document individual Mycoplasma spp. shedding patterns. Four of the Forsten's tortoises and six of the Sulawesi forest turtles tested positive repeatedly for Mycoplasma spp. DNA using a PCR assay. Clarithromycin, a macrolide antibiotic, was administered orally to all animals at 20 mg/kg every 2 to 3 days for a total of 90 days. While no adverse effects were noted, this extended 3 month long course of clarithromycin failed to suppress Mycoplasma spp. shedding in all but one of the 10 Mycoplasma spp. PCR-positive animals.

Citation Download Citation

Christy L. Rettenmund, Donal M. Boyer, William J. Orrico, Sarah G. Parker, Rebecca P. Wilkes, Tracie A. Seimon, and Jean A. Paré "Long-term Oral Clarithromycin Administration in Chelonians with Subclinical Mycoplasma spp. Infection," Journal of Herpetological Medicine and Surgery 27(1-2), 58-61, (1 March 2017). https://doi.org/10.5818/1529-9651-27.1-2.58

Published: 1 March 2017

KEYWORDS/PHRASES

PUBLICATION TITLE:

COLLECTION:

PUBLICATION YEARS